These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 155170)

  • 1. Literature survey of bacterial, fungal, and Drosophila assay systems used in the evaluation of selected chemical compounds for mutagenic activity.
    Brown MM; Wassom JS; Malling HV; Shelby MD; Von Halle ES
    J Natl Cancer Inst; 1979 Apr; 62(4):841-71. PubMed ID: 155170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the mutagenicity and DNA-modifying activity of carcinogens and noncarcinogens in microbial systems.
    Rosenkranz HS; Poirier LA
    J Natl Cancer Inst; 1979 Apr; 62(4):873-92. PubMed ID: 372656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic activity of chemical carcinogens and related compounds in the intraperitoneal host-mediated assay.
    Simmon VF; Rosenkranz HS; Zeiger E; Poirier LA
    J Natl Cancer Inst; 1979 Apr; 62(4):911-8. PubMed ID: 372659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE; Cline JC; Thompson CZ
    Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Problems concerned with microbial mutagenicity tests].
    Gericke D
    Onkologie; 1982 Feb; 5(1):30-2, 34-5. PubMed ID: 6461834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term tests for mutagenesis and carcinogenesis in drug toxicology: how to test and when to test is the question.
    De La Iglesia FA; Lake RS; Fitzgerald JE
    Drug Metab Rev; 1980; 11(1):103-46. PubMed ID: 6448737
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro assays for recombinogenic activity of chemical carcinogens and related compounds with Saccharomyces cerevisiae D3.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):901-9. PubMed ID: 372658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the genetic activity of 5-nitroimidazole derivatives in Escherichia coli, Neurospora crassa, Saccharomyces cerevisiae and Drosophila melanogaster.
    Mohn GR; Ong TM; Callen DF; Kramers PG; Aaron CS
    J Environ Pathol Toxicol; 1979; 2(3):657-70. PubMed ID: 154545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial National Cancer Institute studies on mutagenesis as a prescreen for chemical carcinogens: an appraisal.
    Poirier LA; de Serres FJ
    J Natl Cancer Inst; 1979 Apr; 62(4):919-26. PubMed ID: 372660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation and deactivation of mutagens and carcinogens.
    De Flora S
    Ital J Biochem; 1979; 28(2):81-103. PubMed ID: 399955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-arabinose resistance test with Salmonella typhimurium as a primary tool for carcinogen screening.
    Dorado G; Pueyo C
    Cancer Res; 1988 Feb; 48(4):907-12. PubMed ID: 3276401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of mutagenic impurities in carcinogens and noncarcinogens by high-pressure liquid chromatography and the Salmonella/microsome test.
    Donahue EV; McCann J; Ames BN
    Cancer Res; 1978 Feb; 38(2):431-8. PubMed ID: 340030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay for mutagenicity of bile in Sprague-Dawley rats treated subcutaneously with intestinal carcinogens.
    Moriya M; Ohta T; Sugiyama F; Miyazawa T; Shirasu Y
    J Natl Cancer Inst; 1979 Oct; 63(4):977-82. PubMed ID: 384011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the mutagenicity of compounds of known carcinogenicity, belonging to the benz[a]anthracene, chrysene, and cyclopenta[a]phenanthrene series, using Ames's test.
    Coombs MM; Dixon C; Kissonerghis AM
    Cancer Res; 1976 Dec; 36(12):4525-9. PubMed ID: 793712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forward mutation assay for screening carcinogens by alkaline phosphatase constitutive mutations in Escherichia coli K-12.
    Izutani K; Nakata A; Shinagawa H; Kawamata J
    Biken J; 1980 Jun; 23(2):69-75. PubMed ID: 7006595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of carcinogens and related compounds tested for mutagenic activity.
    Poirier LA; Weisburger EK
    J Natl Cancer Inst; 1979 Apr; 62(4):833-40. PubMed ID: 372655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system.
    Rinkus SJ; Legator MS
    Cancer Res; 1979 Sep; 39(9):3289-318. PubMed ID: 383284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.